Tahir Sheikh

Also affiliated with Boston Medical Center

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors”.

Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0066

N/A

0.689DataRank · unranked

15 citations

Xiao Chen, Xinjing Xu, John T. McGuire, Matthew Ingham, Chao Lü +2 more

A phase 2 study of belinostat and SGI-110 (guadecitabine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps11578

N/A

0.292DataRank · unranked

6 citations

Shing Mirn Lee, Mia C. Weiss, Brittany L. Siontis, Benjamin Powers, Warren Chow +6 more

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11531

N/A

0DataRank · unranked

1 citations

Shing M. Lee, Liner Ge, Mihaela Druta, Anthony P. Conley, Mary Louise Keohan +14 more